Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11386930 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
Conditions: Fabry Disease;   Fabry´s Disease;   Anderson-Fabry Disease
2 Completed Sirolimus for Focal Segmental Glomerulosclerosis
Condition: Focal Glomerulosclerosis
Intervention: Drug: Sirolimus

Indicates status has not been verified in more than two years